184 related articles for article (PubMed ID: 36323529)
1. Construction and validation of an aging-related gene signature for prognosis prediction of patients with breast cancer.
Li J; Qi C; Li Q; Liu F
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1741. PubMed ID: 36323529
[TBL] [Abstract][Full Text] [Related]
2. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
Wang Z; Liu H; Gong Y; Cheng Y
Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
[TBL] [Abstract][Full Text] [Related]
3. Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer.
Wang B; Tong F; Zhai C; Wang L; Liu Y; Wang J
Dis Markers; 2021; 2021():3385058. PubMed ID: 34721733
[TBL] [Abstract][Full Text] [Related]
4. A Novel Aging-Related Prognostic lncRNA Signature Correlated with Immune Cell Infiltration and Response to Immunotherapy in Breast Cancer.
Liu Z; Ren C; Cai J; Yin B; Yuan J; Ding R; Ming W; Sun Y; Li Y
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110517
[TBL] [Abstract][Full Text] [Related]
5. An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Breast Cancer.
Yuan J; Duan F; Zhai W; Song C; Wang L; Xia W; Hua X; Yuan Z; Bi X; Huang J
Int J Womens Health; 2021; 13():1053-1064. PubMed ID: 34785957
[TBL] [Abstract][Full Text] [Related]
6. Nomogram based on autophagy related genes for predicting the survival in melanoma.
Deng G; Wang W; Li Y; Sun H; Chen X; Zeng F
BMC Cancer; 2021 Nov; 21(1):1258. PubMed ID: 34809598
[TBL] [Abstract][Full Text] [Related]
7. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
8. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
10. The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma.
Gu CY; Dai B; Zhu Y; Lin GW; Wang HK; Ye DW; Qin XJ
Mol Med; 2022 Jul; 28(1):78. PubMed ID: 35836112
[TBL] [Abstract][Full Text] [Related]
11. Construction and Validation of a Prognostic Risk Model for Triple-Negative Breast Cancer Based on Autophagy-Related Genes.
Yan C; Liu Q; Jia R
Front Oncol; 2022; 12():829045. PubMed ID: 35186763
[TBL] [Abstract][Full Text] [Related]
12. An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma.
Xu Q; Chen Y
Front Cell Dev Biol; 2021; 9():685379. PubMed ID: 34277626
[TBL] [Abstract][Full Text] [Related]
13. An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Squamous Carcinoma.
Zhai WY; Duan FF; Chen S; Wang JY; Zhao ZR; Wang YZ; Rao BY; Lin YB; Long H
Front Cell Dev Biol; 2022; 10():770550. PubMed ID: 35300428
[TBL] [Abstract][Full Text] [Related]
14. Establishing and Validating an Aging-Related Prognostic Signature in Osteosarcoma.
Ma Y; Zheng S; Xu M; Chen C; He H
Stem Cells Int; 2023; 2023():6245160. PubMed ID: 37964984
[TBL] [Abstract][Full Text] [Related]
15. A signature constructed with mitophagy-related genes to predict the prognosis and therapy response for breast cancer.
Zhao Y; Zhang Y; Dai C; Hong K; Guo Y
Aging (Albany NY); 2022 Aug; 14(15):6169-6186. PubMed ID: 35939339
[TBL] [Abstract][Full Text] [Related]
16. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma.
Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B
Front Oncol; 2022; 12():915662. PubMed ID: 36033441
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of a robust autophagy-related molecular model for predicting the prognosis of breast cancer patients.
Ma JY; Liu Q; Liu G; Peng S; Wu G
Aging (Albany NY); 2021 Jun; 13(12):16684-16695. PubMed ID: 34185683
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of prognostic signature for breast cancer based on genes potentially involved in autophagy.
Zhong S; Chen H; Yang S; Feng J; Zhou S
PeerJ; 2020; 8():e9621. PubMed ID: 33194339
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of Autophagy-Related Gene Signature and Nomogram for Predicting Survival in Oral Squamous Cell Carcinoma.
Hou C; Cai H; Zhu Y; Huang S; Song F; Hou J
Front Oncol; 2020; 10():558596. PubMed ID: 33178587
[TBL] [Abstract][Full Text] [Related]
20. Exploration of prognosis and immunometabolism landscapes in ER+ breast cancer based on a novel lipid metabolism-related signature.
Shen L; Huang H; Li J; Chen W; Yao Y; Hu J; Zhou J; Huang F; Ni C
Front Immunol; 2023; 14():1199465. PubMed ID: 37469520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
